Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study Electrothermocauterisation of Afghan Patients With Anthroponotic Cutaneous Leishmaniasis With and Without Pharmaceutical Chlorite Listed in the German Drug Codex (DAC N-055)

NCT00947362 is registered in ClinicalTrials.gov with Waisenmedizin e. V. Promoting Access to Essential Medicine as lead sponsor.

NCT NCT00947362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00947362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study Electrothermocauterisation of Afghan Patients With Anthroponotic Cutaneous Leishmaniasis With and Without Pharmaceutical Chlorite Listed in the German Drug Codex (DAC N-055)
Lead sponsor
Waisenmedizin e. V. Promoting Access to Essential Medicine
Phase
Phase 2/3
Overall status
Completed
Start date
August 1, 2004
Completion date
December 15, 2007
Enrollment
134 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

wound healing